TRACON Pharmaceuticals Closes On $14M
TRACON Pharmaceuticals Inc., a biopharmaceutical company developing treatments for cancer, has closed on a $14 million first tranche of venture financing. JAFCO and Nextech Invest co-led the round, which included investments from Arcus Ventures, Brookline Investments and BHP. JAFCO’s Kenji Harada and Hironori Hozoji, and Nextech Invest’s Myoung-Ok Kwon, will join the company’s board as a result of the round. San Diego-based TRACON will use the money to continue development of its treatments.
20 April 2011•4 mins read
